Dublin, Nov. 30, 2018 (GLOBE NEWSWIRE) -- The "Antibiotics: Global Markets to 2023" report has been added to ResearchAndMarkets.com's offering.

This research report categorizes the antibiotics market by type. The product types are beta-lactams, fluoroquinolones, macrolides, tetracycline and other antibiotic classes.

The antibiotics market growth outlook is positive with significant growth potential for beta lactams and tetracyclines antibiotic drugs. There is pressure on antibiotic drug manufacturers to offer antimicrobial-resistant drugs at affordable prices. At the same time, factors such as rising disposable incomes and increasing spending on healthcare in emerging markets, increasing grants from government agencies for antibiotic drugs research and development and rising incidence of infectious diseases are contributing to the growth of the market.

The market for antibiotics is fragmented. Major players in the market are Merck & Company, Inc., Pfizer Inc., Sanofi S.A., Novartis AG, Bayer AG and others. Major factors for this growth include increasing use of these drugs to treat acne and other skininfections and respiratory tract infections such as pneumonia, and genital and urinary infections.

The antibiotics market is challenged by restraints such as low return on investment, pricing pressure from regulators, antimicrobial resistance, drug patents expiry and antibiotics drug shortages.

Report Includes

Key Topics Covered:

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown

Chapter 2 Summary and Highlights

Chapter 3 Antibiotics Market Overview
Antibiotics Market Characteristics
Beta-lactams
Fluoroquinolones
Macrolides
Tetracycline
Other Antibiotic Classes
Value Chain
Drug Discovery
Drug Development
Clinical Trials
Drug Review and Registration
Manufacturing
Distribution
End-users
Antibiotics Market Size and Growth
Market Size
Historic Market Growth
Drivers of the Market
Restraints on the Market
Forecast Market Growth
Drivers of the Market
Restraints on the Market
Global Antibiotics Market, by Segment
Global Antibiotics Market, Historic and Forecast, by Segment, 2014-2023
Antibiotics Industry Trends and Strategies
Global Research Initiatives and Funding
3D Printing Technology
Increasing Focus on Antibiotic Drug Development by Smaller Pharmaceutical Firms

Chapter 4 Antibiotics Market Global Clinical Development Pipeline
Introduction
Antibiotic Agents in Clinical Development
Analysis of Clinical Development Pipeline

Chapter 5 Global Antibiotics Market Comparison with Macro Economic Factors
Global Per Capita Average Antibiotics Market Expenditure
Per Capita Average Antibiotics Market Expenditure, by Country
Global Antibiotics Market Size, Percentage of GDP
Global Antibiotics Market Size, Percentage of GDP, by Country

Chapter 6 Antibiotics Market Regional and Country Analysis
Global Antibiotics Market, by Region
Global Antibiotics Market, Historic and Forecast, by Region, 2014-2023
Global Antibiotics Market Segmentation, by Region, 2018
Global Antibiotics Market, by Country
Global Antibiotics Market, Historic and Forecast, by Country
Global Antibiotics Market Segmentation, by Country, 2018

Chapter 7 Asia-Pacific Antibiotics Market

Chapter 8 Western Europe Antibiotics Market

Chapter 9 Eastern Europe Antibiotics Market

Chapter 10 North America Antibiotics Market

Chapter 11 South America Antibiotics Market

Chapter 12 Middle East Antibiotics Market

Chapter 13 Africa Antibiotics Market

Chapter 14 Antibiotics Market Competitive Landscape
Company Profiles
Bayer AG
Merck & Company, Inc.
Novartis AG
Pfizer Inc.
Sanofi S.A.

Chapter 15 Key Mergers and Acquisitions in the Antibiotics Market
Merck Acquired Cubist
Pfizer Acquired AstraZeneca's Antibiotics Division
Actavis Acquired Durata Therapeutics
Melinta Acquired the Medicines Company's Antibiotics Division
PharmAthene Merged With Altimmune

For more information about this report visit https://www.researchandmarkets.com/research/9mmfg7/global?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Diseases Drugs, Antibiotics